Cite

HARVARD Citation

    Hochstrasser, T. et al. (2018). Do pre-clinical multiple sclerosis models allow us to measure neurodegeneration and clinical progression?. Expert review of neurotherapeutics. pp. 351-353. [Online]. 
  
Back to record